We believe that connected data leads to a clearer picture. We help clients can make accurate, high value decisions that ensure therapies get to the patients faster. Our seamless view of the industry builds your understanding of the commercial issues that affect strategic decisions — so you can turn understanding into insight, and insight into action.
From market sizing and commercial opportunity assessment, to competitive intelligence and deal benchmarking, Evaluate is here to help. Our insights solutions put the data you need at your fingertips, while our experts are here to deliver tailored guidance.
Evaluate is proud to be part of Norstella – an organisation that unites five market-leading companies with a shared goal: to improve patient access to life-changing therapies. We are stronger together – and as Norstella company, Evaluate plays a key role in helping you connect the dots from pipeline to patient.
Evaluate opens in London, UK
Goodbye CD Rom! EvaluatePharma.com goes live
Hi Boston! Evaluate opens in the US
First Evaluate World Preview report published
Hurrah! Evaluate wins Queen’s Award for Enterprise – International Trade
Evaluate European Drug Forecasts launch
Evaluate Epi Analyzer and Japan Drug Forecasts launche
Evaluate Omnium launches
Brave new world! Evaluate becomes part of Norstella
2023: Evaluate launches CDMO solution and wins Best Decision Management Solution at AI Breakthrough Awards
Build insight and value. Improve patient outcomes. Do you want to work with clients that have a global impact? Do you want to be part of our ongoing growth? Explore all our opportunities.